Monday Morning Update 2/20/23

Monday Morning Update 2/20/23

Top News

The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”

Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…

Continue Reading
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…

Continue Reading
The Adderall Shortage

The Adderall Shortage

The current Adderall shortage is of serious concern to both patients who have attention deficit hyperactivity disorder (ADHD) and clinicians. This shortage cannot be quickly alleviated by a simple increase in the amount of medication manufactured, unless the upper limit to the amount of Adderall’s active ingredient that can be manufactured in a given year is raised by the Drug Enforcement Agency (DEA). The limit has been imposed because the active ingredient can be abused as a recreational drug. It is necessary to control the supply of any medication with abuse liability, but this must be achieved without compromising the legitimate…

Continue Reading
Medication risk analysis company MDI Health raises $20M

Medication risk analysis company MDI Health raises $20M

Healthcare analytics company MDI Health scored $20 million in Series A funding, bringing the company’s total funding to $26 million.Intel Capital led the round, with participation from Maverick Ventures Israel, alongside existing investors Fresh.Fund, Arc Impact, Hanaco Ventures, Jumpspeed Ventures, former Optum senior vice president Richard Montwill, Welltech Ventures and Basad Ventures.
Yoni Greifman, Intel Capital’s investment director, will join MDI’s board of directors.
WHAT IT DOES
Israel-based MDI offers an AI-enabled tool that provides medication risk analysis based on a patient’s medical records with the aim of preventing adverse drug reactions.
The funds will help the company scale its U.S. and Israeli research and…

Continue Reading
Home Healthcare Market is Expected to Reach $340.2B

Home Healthcare Market is Expected to Reach $340.2B

What You Should Know:– Home Healthcare market in terms of revenue was estimated to be worth $226 Billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.– The report reveals growth in this market is mainly driven by rapid growth in the elderly population, and the rising incidence of chronic diseases.Rising Demand for Home-Health Services & SolutionsThe home healthcare industry is expected to experience rapid growth in the near future due to increased demand for home-based care services. The aging population,…

Continue Reading
Digital as the Differentiator for Biopharma and Medtech

Digital as the Differentiator for Biopharma and Medtech

With the Inflation Reduction Act now on the books, the U.S. Centers for Medicare & Medicaid Services (CMS) will begin negotiating drug prices with the pharmaceutical industry. That, combined with other headwinds such as increased competition from me-too drugs, and ever-present pricing pressure from payers, means that pharma players now more than ever need a new and powerful tool to differentiate their products. We believe the next decade of transformation is digital.
Learning from the auto industry Almost every industry has had to confront a fundamental existential question: What is our product? Consider the automotive industry, which once was largely about hardware…

Continue Reading
HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

The U.S. Department of Health & Human Services (HHS) unveiled three new models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models include access to $2 generic drugs.
The news is in response to President Joe Biden’s executive order issued in October, which directed HHS to find ways to lower prescription drug costs and improve access to drug therapies for those enrolled in Medicare and Medicaid health plans. The models are meant to build on the Inflation Reduction Act of 2022, which includes allowing Medicare to negotiate lower prescription drug prices for…

Continue Reading
KLAS: What Impact Do Automated Prior Authorization Solutions Provide?

KLAS: What Impact Do Automated Prior Authorization Solutions Provide?

What You Should Know:– Prior authorization is mandated by payers to ensure that certain clinical procedures and medications being ordered are necessary. To alleviate the heavy administrative burden this requirement causes, healthcare organizations have adopted automated prior authorization solutions.– For this report, KLAS interviewed 30 respondents from 26 unique organizations to understand their experiences using these solutions and what outcomes they have seen.Understanding the Impact Automated Prior Authorization Solutions ProvideThis report is a perception study designed to help readers understand where the automated prior authorization market is and what outcomes organizations using automated prior authorization are seeing. To gather these perspectives, KLAS…

Continue Reading
Memorial Healthcare System grows its telehealth offering to 61 programs

Memorial Healthcare System grows its telehealth offering to 61 programs

Before the widespread adoption of telemedicine technology, there were several problems that hindered the delivery of healthcare services for most healthcare organizations.THE PROBLEM
One of the main problems was access to healthcare, particularly with working families and those with chronic conditions. Many people lacked convenient access to medical care and providers, making it difficult for them to receive the care they needed.
Another problem was the cost of healthcare, which could be prohibitively expensive for many people. This was especially true for those without insurance or with limited coverage. Additionally, long wait times for appointments and limited availability of specialists further exacerbated the…

Continue Reading